IMMUVERA THERAPEUTICS AS

Operating

Selskapet skal utvikle produkter innenfor 'life science' og utføre konsulent, og forskningsoppdrag på vegne av kunder.

Keywords

engineering servicespowerenergytransportwatersewagedrainageindustrymanufacturingtelecommunicationsbroadcastingpolicy analysisregulationsexpert opinionswitness statementsmechanical engineeringautomotive engineeringchemical engineeringtechnical consulting

Organization

CEO: JS
Jørund Sollid1976
Chairman of the board: MS
Marcus Sahlin Pettersen1978
Years since formation: 6 years; since Dec 5, 2020
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 6,529,800; 1 share class
Total number of shareholders: 1057; 135 companies, 922 persons
Belongs to group of

Financials

Total operating income 2025: 3,436,620; NOK
Annual total result 2025: -3,829,553; NOK
Total equity 2025: 22,009,626; NOK

Last update: Sep 11, 2026

Management

Management / administration

Name	Role	Shares
JS Jørund Sollid 1976	Managing Director/CEO	-

Board

Name	Role	Shares
MS Marcus Sahlin Pettersen 1978	Chairman	10.09 % indirectly
KM Kristin Malene Bjerke 1987	Board Member	4.75 % indirectly
BH Benedicte Heidenreich Fossum 1962	Board Member	-
JC Jostein Christian Dalland 1969	Board Member	-

Others

Name	Role	Shares
F FIRST ACCOUNTING AS	Accountant	-
I INSIGNIS AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
MS Marcus Sahlin Pettersen 1978	Chairman	10.09 % indirectly
CC Christian Claus Bothmann 1965	-	8.22 % directly < 0.01 % indirectly 8.21 %
KM Kristin Malene Bjerke 1987	Board Member	4.75 % indirectly
LE Lars Espen Strand Nordhus 1988	-	3.77 % indirectly
JB Jørgen Bakke 1951	-	2.4 % indirectly
EE Eduard Emilian Grieg 1966	-	1.8 % directly
EC Espen Christopher Fasting 1969	-	1.65 % indirectly
NB Nils Berg Johansen 1975	-	1.62 % indirectly
TH Trond Havdahl 1960	-	1.53 % indirectly
LB Lars Buer 1957	-	1.53 % directly

Last update: Sep 11, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
A ALV AS	Ordinary shares	2,088,340	31.98 %
E ESTER 4.14 AS	Ordinary shares	536,200	8.21 %
N NISTADGRUPPEN AS	Ordinary shares	310,000	4.75 %
A AMBROSIA AS	Ordinary shares	253,300	3.88 %
G GANDALF AS	Ordinary shares	177,271	2.71 %
P POLAR PRODUCTION AS	Ordinary shares	157,000	2.4 %
EE Eduard Emilian Grieg 1966	Ordinary shares	117,396	1.8 %
B BRAK INVEST AS	Ordinary shares	100,000	1.53 %
M M3 HOLDING AS	Ordinary shares	100,000	1.53 %
LB Lars Buer 1957	Ordinary shares	100,000	1.53 %
O OSLO KAPITALFORVALTNING AS	Ordinary shares	98,000	1.5 %
E ECF HOLDING AS	Ordinary shares	82,200	1.26 %
CM Christian Mjaaseth 1973	Ordinary shares	70,000	1.07 %
HG Hm Gram Enterprises Ltd (Ηε302283)	Ordinary shares	66,265	1.01 %
G GAZPACHO AS	Ordinary shares	60,000	0.92 %
J JJINVEST AS	Ordinary shares	57,786	0.88 %
M MOFA INVEST AS	Ordinary shares	50,450	0.77 %
I INGEBJØRG BRATLAND AS	Ordinary shares	50,000	0.77 %
A ASKAMA AS	Ordinary shares	48,720	0.75 %
H HANDSUP HOLDING AS	Ordinary shares	40,000	0.61 %
Ø ØKONOMI & BALANSE AS	Ordinary shares	39,874	0.61 %
G GLINDØ HOLDING AS	Ordinary shares	37,859	0.58 %
C C. EMTOR EIENDOM AS	Ordinary shares	37,625	0.58 %
A ASE INVEST AS	Ordinary shares	36,095	0.55 %
D DAJEDE AS	Ordinary shares	35,000	0.54 %
HK Håvard Kirkhus 1976	Ordinary shares	34,248	0.52 %
T TICA AS Under liquidation	Ordinary shares	33,459	0.51 %
A ARCH HOLDING AS	Ordinary shares	33,300	0.51 %
T TOP SECRET INVEST AS	Ordinary shares	31,000	0.47 %
LN Livar Nedrebø 1968	Ordinary shares	30,055	0.46 %
C CHRISTIANIA FINANS AS	Ordinary shares	30,000	0.46 %
M MAJOR MAJOR AS	Ordinary shares	25,126	0.38 %
L LÅSBUA AS	Ordinary shares	25,000	0.38 %
K KARDIOKONSULT AS	Ordinary shares	25,000	0.38 %
IY Ingrid Ylva Sahlin 1953	Ordinary shares	23,493	0.36 %
ZM Zhanel Mukhamedova 1989	Ordinary shares	20,344	0.31 %
E ESS INVESTMENT AS	Ordinary shares	20,000	0.31 %
CA Christopher Aalholm 1969	Ordinary shares	20,000	0.31 %
CM Celine Maria Sedal 1996	Ordinary shares	20,000	0.31 %
B BAKS HOLDING AS	Ordinary shares	17,626	0.27 %
ES Erik Stubø 1959	Ordinary shares	16,000	0.25 %
JO John Ola Larsen Hjelle 1983	Ordinary shares	15,875	0.24 %
B BLOMGREN HOLDING AS	Ordinary shares	15,500	0.24 %
JM Johannes Michael Mollø-Christensen 1965	Ordinary shares	15,000	0.23 %
OM Ole-Kristian Martinsen 1983	Ordinary shares	15,000	0.23 %
KA Kim Anders Øvrid 1976	Ordinary shares	15,000	0.23 %
T TM VERDI AS	Ordinary shares	14,800	0.23 %
PM Per Marius Vinsdal 1972	Ordinary shares	14,100	0.22 %
RM Richard M Edvinsen 1985	Ordinary shares	12,000	0.18 %
TE Tom Erik Van Oorschot 1962	Ordinary shares	11,938	0.18 %
I IMMUVERA THERAPEUTICS AS	Ordinary shares	11,672	0.18 %
SM Snorre Moxnes 1967	Ordinary shares	11,000	0.17 %
P PUSEHUSET HOLDING AS	Ordinary shares	10,900	0.17 %
P PRODUKSJONSBOKSEN AS	Ordinary shares	10,876	0.17 %
NA Nils Arne Susort 1988	Ordinary shares	10,500	0.16 %
TR Tom Roger Nilsen 1978	Ordinary shares	10,083	0.15 %
KP Klaus Petter Sørensen 1981	Ordinary shares	10,000	0.15 %
HJ Håkon Johan Myhre 1966	Ordinary shares	10,000	0.15 %
SØ Sveinung Østgård 1985	Ordinary shares	10,000	0.15 %
SH Stein Halvorsen 1969	Ordinary shares	10,000	0.15 %
J JEB AS	Ordinary shares	10,000	0.15 %
HS Halvard Sæther 1972	Ordinary shares	10,000	0.15 %
ES Erling Sigurd Johannessen 1953	Ordinary shares	10,000	0.15 %
H HÅBJØRG INVEST AS	Ordinary shares	10,000	0.15 %
S STANDAL AS	Ordinary shares	10,000	0.15 %
N NARANMO AS	Ordinary shares	9,988	0.15 %
SM Stian Martinussen 1981	Ordinary shares	9,574	0.15 %
S SOBISA AS	Ordinary shares	9,246	0.14 %
A ANNA RATHE HOLDING AS	Ordinary shares	9,195	0.14 %
KS Koen Santifort	Ordinary shares	9,055	0.14 %
SH Sven-Olai Høyland 1961	Ordinary shares	9,000	0.14 %
G GBOGH HOLDING AS	Ordinary shares	9,000	0.14 %
ØD Øystein Davidsen 1962	Ordinary shares	9,000	0.14 %
R RYGA INVEST AS	Ordinary shares	8,981	0.14 %
CM Christian Maurangsnes Mæland 1979	Ordinary shares	8,696	0.13 %
JE John-Arvid Eik 1983	Ordinary shares	8,550	0.13 %
TA Tor Andre Haveland 1970	Ordinary shares	8,500	0.13 %
U ULVUND INVEST AS	Ordinary shares	8,400	0.13 %
E EJ RÅDGIVNING AS	Ordinary shares	8,300	0.13 %
L LEMBAS AS	Ordinary shares	8,192	0.13 %
SA Shahram Ariafar 1975	Ordinary shares	8,175	0.13 %
F FABE INVEST AS	Ordinary shares	7,834	0.12 %
C CANLUP AS	Ordinary shares	7,834	0.12 %
LH Lars Helge Brunborg 1948	Ordinary shares	7,700	0.12 %
EV Erik Van Der Linden 1990	Ordinary shares	7,375	0.11 %
OA Ole Andreas Heen 1972	Ordinary shares	7,137	0.11 %
V VOLL TECHNOLOGY AS	Ordinary shares	6,337	0.1 %
AM Aleksi Miikkael Luukkonen 1991	Ordinary shares	6,231	0.1 %
AH Andre Hurni	Ordinary shares	6,219	0.1 %
KH Kjersti Haugen 1930	Ordinary shares	6,214	0.1 %
MS Martin Steen 1973	Ordinary shares	6,175	0.09 %
W WATERFALL MUSIC AS	Ordinary shares	6,000	0.09 %
GH Gunilla Hagstedt	Ordinary shares	6,000	0.09 %
TB Toril Beate Nilsen 1966	Ordinary shares	6,000	0.09 %
FG Francesca Gatti 1979	Ordinary shares	5,875	0.09 %
JU John Ulriksen 1963	Ordinary shares	5,856	0.09 %
PM Petter Myrvold 1982	Ordinary shares	5,770	0.09 %
AM Asbjørn Moen 1963	Ordinary shares	5,764	0.09 %
A ALT UNDER KONTROLL AS	Ordinary shares	5,678	0.09 %
TM Tillik Margrete Motzfeldt Haustveit 1981	Ordinary shares	5,600	0.09 %

Shares owned by the IMMUVERA THERAPEUTICS AS

Name	Share class	Total number of shares	Share
A ALVIRAL AS Closed	Ordinary shares	297,000	99 %
I IMMUVERA THERAPEUTICS AS	Ordinary shares	11,672	0.18 %

Last update: Sep 25, 2026

Group structure

IMMUVERA THERAPEUTICS AS
Total operating income 2025: NOK 3,436,620
Operating profit 2025: NOK -3,842,679
Employees: 0

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	3,436,620	220,410	771,701	100,000	208,442
Annual Total Result	-3,829,553	-5,918,424	-4,830,116	-6,094,266	-6,380,639
Total assets	27,168,462	20,556,270	13,409,838	7,310,721	1,913,532
Total liabilities	5,158,836	4,739,545	1,248,799	3,093,023	3,295,683
Total equity	22,009,626	15,816,725	12,161,039	4,217,698	-1,382,151

P&L

Year	2025	2024	2023	2022	2021
Total operating income	3,436,620	220,410	771,701	100,000	208,442
Total operating costs	7,279,298	6,129,511	5,575,887	6,188,261	6,587,992
Operating result	-3,842,679	-5,909,101	-4,804,185	-6,088,261	-6,379,550
Financial income/costs	13,126	-9,323	-25,931	-6,005	-1,089
Profit before tax	-3,829,553	-5,918,424	-4,830,116	-6,094,266	-6,380,639
Total tax & extraordinary income/cost	0	0	0	0	0
Annual Total Result	-3,829,553	-5,918,424	-4,830,116	-6,094,266	-6,380,639

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	18,293,027	15,318,855	8,697,437	4,579,794	22,967
Total current assets	8,875,435	5,237,415	4,712,401	2,730,927	1,890,565
Total assets	27,168,462	20,556,270	13,409,838	7,310,721	1,913,532
Short term debt	1,238,943	1,838,909	1,248,799	2,846,408	3,295,683
Long term debt	3,919,893	2,900,636	0	246,615	0
Total liabilities	5,158,836	4,739,545	1,248,799	3,093,023	3,295,683
Contributed capital	22,009,626	15,816,725	12,194,180	4,217,698	4,998,488
Retained earnings	0	0	-33,141	0	-6,380,639
Total equity	22,009,626	15,816,725	12,161,039	4,217,698	-1,382,151
Total equity and liabilities	27,168,462	20,556,270	13,409,838	7,310,721	1,913,532

Classification

21st company classification

BETA

Scaleup

IMMUVERA THERAPEUTICS AS926 109 553

IMMUVERA THERAPEUTICS AS

Keywords

Organization

Ownership

Financials

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Shares owned by the IMMUVERA THERAPEUTICS AS

Group structure

Financials

Summary

P&L

Balance overview

Classification